ArticleEmerging microbes & infections2021

Long-term humoral immunogenicity, safety and protective efficacy of inactivated vaccine against COVID-19 (CoviVac) in preclinical studies.

Liubov I Kozlovskaya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.